Proceedings of the 2022 ‘AISYIYAH International Conference on Health and Medical Sciences (A-HMS 2022)

Latex Agglutination Method for Determination of von Willebrand Factor Antigen in Patients with Bleeding Disorders

Authors
Rahayu Anggraini1, *, Devyana Dyah Wulandari1, Novera Herdiani1, Lono Wijayanti2, Riska Rohmawati2
1Faculty of Health, Universitas Nahdlatul Ulama Surabaya, Surabaya, East Java, Indonesia
2Faculty of Nursing and Midwifery, Universitas Nahdlatul Ulama Surabaya, Surabaya, East Java, Indonesia
*Corresponding author. Email: anggrek@unusa.ac.id
Corresponding Author
Rahayu Anggraini
Available Online 27 July 2023.
DOI
10.2991/978-94-6463-190-6_20How to use a DOI?
Keywords
von willebrand factor antigen; latex agglutination method; bleeding disorders
Abstract

Measurement of the level of von Willebrand factor antigen (VWF:Ag) in human plasma is usually carried out in a specialized laboratory in routine clinical practice and is carried out by the ELISA method which takes a long time or immunoturbidimetry which is less sensitive and specific. The purpose of this study was to qualitatively determine the von Willebrand factor (VWF) antigen in only a maximum of 5 min using the latex agglutination method. The research design is an exploratory laboratory experiment. This study was conducted in a cross sectional manner in patients with bleeding disorders with prolonged bleeding time and healthy individuals. The research stage is to prepare a VWF polyclonal antibody from Invitrogen Ref. Pa5–16634 with Lot No. XE3587846A in 0.1M MES{2-(N-morpholino) ethane-sulfonic acid buffer, 0.9% sodium chloride, pH 6, to be sensitized to Carboxyl latex, 4% w/v 1 m. Latex particles after passive adsorption, polyclonal antibodies stick to the latex surface. The patient's citrate blood sample is taken which will be compared with the normal individual's citrate blood. The results showed agglutination in patients with bleeding disorders and no agglutination in normal individuals. In conclusion, latex reagent containing polyclonal VWF can be used as a diagnostic tool to determine VWF antigen in patients with bleeding disorders.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 2022 ‘AISYIYAH International Conference on Health and Medical Sciences (A-HMS 2022)
Series
Advances in Health Sciences Research
Publication Date
27 July 2023
ISBN
10.2991/978-94-6463-190-6_20
ISSN
2468-5739
DOI
10.2991/978-94-6463-190-6_20How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Rahayu Anggraini
AU  - Devyana Dyah Wulandari
AU  - Novera Herdiani
AU  - Lono Wijayanti
AU  - Riska Rohmawati
PY  - 2023
DA  - 2023/07/27
TI  - Latex Agglutination Method for Determination of von Willebrand Factor Antigen in Patients with Bleeding Disorders
BT  - Proceedings of the 2022 ‘AISYIYAH International Conference on Health and Medical Sciences (A-HMS 2022)
PB  - Atlantis Press
SP  - 159
EP  - 164
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-190-6_20
DO  - 10.2991/978-94-6463-190-6_20
ID  - Anggraini2023
ER  -